Company: DVAX
Filing Date: 2025-02-20
Form Type: 8-K
Source: 0001029142-25-000047
Chunk: 1

Company: DYNAVAX TECHNOLOGIES CORP
Filing Date: 2025-02-20
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01 Financial Statements and Exhibits.

(d) Exhibits. The following exhibit is furnished herewith:

  99.1      Press release dated February 20, 2025 titled "Dynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance. "  
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
   104      Cover Page Interactive Data File (embedded within the Inline XBRL document)                                                                                          

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

                                             Dynavax Technologies Corporation  
  Date:      February 20, 2025      By:      /s/ Kelly MacDonald               
                                             Kelly MacDonald